Global cancer statistics, 2012, Global cancer statistics, pp.87-108, 2012. ,
DOI : 10.1038/nrc1948
Openlabel , uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity Fig. 5. Correlation between mRNA levels of Tim-3 (x-axis) and PD-1, CTLA-4, LAG-3, and TGF? (y-axis) in expanded TILs, Linear trend lines and regression coefficients are shown ,
Dysfunction of HPV16-specific CD8+ T cells derived from oropharyngeal tumors is related to the expression of Tim-3 but not PD-1, Oral Oncology, vol.82, pp.75-82, 2018. ,
DOI : 10.1016/j.oraloncology.2018.05.010
, of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy, J Clin Oncol, vol.25, pp.2171-2178, 2007.
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial, The Lancet Oncology, vol.17, issue.7, pp.956-65, 2016. ,
DOI : 10.1016/S1470-2045(16)30066-3
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study, Journal of Clinical Oncology, vol.35, issue.14, pp.1542-1551, 2017. ,
DOI : 10.1200/JCO.2016.70.1524
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck, New England Journal of Medicine, vol.375, issue.19, pp.1856-67, 2016. ,
DOI : 10.1056/NEJMoa1602252
T cell dysfunction in melanoma patients, The Journal of Experimental Medicine, vol.18, issue.10, pp.2175-86, 2010. ,
DOI : 10.1038/ni1271
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints, Nature Communications, vol.43, p.10501, 2016. ,
DOI : 10.1093/nar/gkv007
Biology of Human Papillomavirus Infection and Immune Therapy for HPV-Related Head and Neck Cancers, Otolaryngologic Clinics of North America, vol.45, issue.4, pp.807-829, 2012. ,
DOI : 10.1016/j.otc.2012.04.005
PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer, Cancer Research, vol.73, issue.1, pp.128-166, 2013. ,
DOI : 10.1158/0008-5472.CAN-12-2606
Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery, Vaccine, vol.27, issue.40, pp.5450-5459, 2009. ,
DOI : 10.1016/j.vaccine.2009.07.005
Intra-cheek immunization as a novel vaccination route for therapeutic vaccines of head and neck squamous cell carcinomas using plasmo virus-like particles, OncoImmunology, vol.56, issue.7, p.1164363, 2016. ,
DOI : 10.1158/0008-5472.CAN-12-2606
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia, New England Journal of Medicine, vol.361, issue.19, pp.1838-1885, 2009. ,
DOI : 10.1056/NEJMoa0810097
Antitumor Activity of Human Papillomavirus Type 16 E7???Specific T Cells against Virally Infected Squamous Cell Carcinoma of the Head and Neck, Cancer Research, vol.65, issue.23, pp.11146-55, 2005. ,
DOI : 10.1158/0008-5472.CAN-05-0772
Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer, International Journal of Cancer, vol.358, issue.2, pp.74-85, 2012. ,
DOI : 10.1056/NEJMoa072685
URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.26497/pdf
The detection of circulating human papillomavirus-specific T cells is associated with improved survival of patients with deeply infiltrating tumors, International Journal of Cancer, vol.104, issue.2, pp.379-89, 2011. ,
DOI : 10.1111/j.1048-891X.2004.014211.x
T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx, International Journal of Cancer, vol.62, issue.8, pp.1984-91, 2006. ,
DOI : 10.1046/j.1365-2567.2002.01442.x
Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma GP5+/6+ PCR followed by reverse line blot analysis enables rapid and highthroughput identification of human papillomavirus genotypes, Oncoimmunology J Clin Microbiol, vol.440, pp.779-87, 2002. ,
The role of human papillomavirus in head and neck cancer, APMIS, vol.49, issue.3 Pt 1, pp.510-519, 2010. ,
DOI : 10.1177/000348940911801010
Immune Response During Therapy With Cisplatin or Radiation for Human Papillomavirus???Related Head and Neck Cancer, Archives of Otolaryngology???Head & Neck Surgery, vol.135, issue.11, pp.1137-1183, 2009. ,
DOI : 10.1001/archoto.2009.159
URL : http://archotol.jamanetwork.com/data/journals/otol/9846/ooa90089_1137_1146.pdf
Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia, British Journal of Cancer, vol.43, issue.7, pp.1129-1165, 2010. ,
DOI : 10.1158/1078-0432.CCR-05-1244
URL : http://www.nature.com/bjc/journal/v102/n7/pdf/6605611a.pdf
T cell exhaustion, Nature Immunology, vol.460, issue.6, pp.492-501, 2011. ,
DOI : 10.4049/jimmunol.0901297
Selection of CD8+PD-1+ Lymphocytes in Fresh Human Melanomas Enriches for Tumor-reactive T Cells, Journal of Immunotherapy, vol.33, issue.9, pp.956-64, 2010. ,
DOI : 10.1097/CJI.0b013e3181fad2b0
Radiotherapy Increases the Permissiveness of Established Mammary Tumors to Rejection by Immunomodulatory Antibodies, Cancer Research, vol.72, issue.13, pp.3163-74, 2012. ,
DOI : 10.1158/0008-5472.CAN-12-0210
URL : http://cancerres.aacrjournals.org/content/canres/72/13/3163.full.pdf
T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma, Cancer Research, vol.77, issue.5, pp.1075-82, 2017. ,
DOI : 10.1158/0008-5472.CAN-16-0274
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity, The Journal of Experimental Medicine, vol.207, issue.10, pp.2187-94, 2010. ,
DOI : 10.1038/nri1936
URL : http://jem.rupress.org/content/jem/208/6/1331.full.pdf
Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer, OncoImmunology, vol.6, issue.1, p.1261779, 2017. ,
DOI : 10.4049/jimmunol.1102609
URL : http://europepmc.org/articles/pmc5283618?pdf=render
Metabolic Instruction of Immunity, Cell, vol.169, issue.4, pp.570-86, 2017. ,
DOI : 10.1016/j.cell.2017.04.004
URL : http://europepmc.org/articles/pmc5648021?pdf=render
Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1, Clinical & Experimental Immunology, vol.43, issue.3, pp.455-66, 2017. ,
DOI : 10.1111/1346-8138.13339
URL : http://onlinelibrary.wiley.com/doi/10.1111/cei.12949/pdf
The Common ??-Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Induce the Expression of Programmed Death-1 and Its Ligands, The Journal of Immunology, vol.181, issue.10, pp.6738-6784, 2008. ,
DOI : 10.4049/jimmunol.181.10.6738
T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer, Proceedings of the National Academy of Sciences, vol.107, issue.17, pp.7875-80, 2010. ,
DOI : 10.1038/ni.1679
URL : http://www.pnas.org/content/107/17/7875.full.pdf
Dysfunction of HPV16-specific CD8+ T cells derived from oropharyngeal tumors is related to the expression of Tim-3 but not PD-1, Oral Oncology, vol.82, pp.75-82, 2018. ,
DOI : 10.1016/j.oraloncology.2018.05.010